MPDL3280A: Immunotherapy Drug Shows Promise Against Range Of Cancers
The drug, called MPDL3280A, significantly shrank tumors in 21 percent of 140 patients with advanced melanoma, lung cancer
mpdla immunotherapy drug show promise range cancers drug call mpdla significantly shrank tumor percent patient advanced melanoma lung cancer